Safety
Compounded vs brand semaglutide: pharmacology
Same active-ingredient name, but important differences worth understanding.
Quick Answer
Compounded semaglutide is prepared by pharmacies and is not FDA-approved, unlike Wegovy, Ozempic and Rybelsus. It may differ in concentration, excipients and, importantly, in the form used — the FDA has flagged concerns about semaglutide salt forms (e.g., sodium, acetate) that differ from the approved base. Branded efficacy and safety data should not be assumed to apply. Always verify what you receive.
Key Facts
- Branded semaglutide is FDA-approved; compounded is not FDA-reviewed
- Compounded products can differ in concentration and excipients
- FDA has flagged semaglutide salt forms (sodium/acetate) vs the approved base
- Branded trial data do not automatically transfer to compounded products
- Verify the pharmacy, the active form, and dosing for your preparation
The core distinction
Branded Wegovy, Ozempic and Rybelsus are FDA-approved finished products from Novo Nordisk, manufactured and tested to defined standards. Compounded semaglutide is prepared by a licensed pharmacy for a prescription and is not FDA-approved; the FDA does not review compounded products for safety, efficacy or quality the way it does approved drugs.
Where they can differ
Compounded preparations may differ in concentration (affecting injection volume), in excipients, and in packaging and beyond-use dating. The FDA has specifically raised concerns about the use of semaglutide salt forms (such as semaglutide sodium or acetate) that differ from the approved semaglutide base — these are not the same as the studied active ingredient.
Quality signals
Because oversight differs, the pharmacy is the key quality signal: whether it is a named, licensed 503A or 503B facility, whether the product is the semaglutide base, and whether a certificate of analysis is available verifying identity, potency and purity. See the provider directory.
Regulatory backdrop
The legal basis for compounding semaglutide depends on FDA shortage and bulks-list designations, which shifted after the shortage was declared resolved in 2025 — see our regulatory hub. This affects availability and is evolving; verify current status with the FDA. This is educational, not an endorsement of compounded products.
Frequently asked questions
Is compounded semaglutide the same as Wegovy or Ozempic?
No. Wegovy, Ozempic and Rybelsus are FDA-approved; compounded semaglutide is pharmacy-prepared, not FDA-reviewed, and can differ in concentration, excipients and form (including salt forms the FDA has flagged).
Why can compounded pricing be lower?
Compounded products are not the branded, FDA-approved drug and are priced differently; lower price does not imply equivalence. Verify quality, the active form, and legality.
References
- U.S. Food and Drug Administration. Wegovy, Ozempic and Rybelsus (semaglutide) prescribing information. Novo Nordisk.
- Knudsen LB, Lau J. The discovery and development of liraglutide and semaglutide. Front Endocrinol. 2019;10:155.
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384:989-1002.
Citations are for educational reference; this article summarizes published research in plain language and is not medical advice.
Bottom Line
Compounded semaglutide is not FDA-approved and can differ from the brand in concentration and form — including salt forms the FDA has flagged. The pharmacy and active form are the key things to verify. Lower price doesn't mean equivalence.
Related from the Journal
Wegovy vs Ozempic vs compounded
Product differences.
Regulatory hub
FDA status & 2026 rules.
Injection & storage
Handling basics.